Investor List:

Top Pharmaceuticals Series A Investors in Israel (24)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Pharmaceuticals investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Avi Rosenbaum, Partner at Tectonic Capital
Avi Rosenbaum
Sweet spot: $250K
Range: $50K - $500K
Investors in New York City, Investors in Boston / New England, Investors in SF Bay Area (CA), Investors in San Diego (CA), Investors in Israel, Investors in Europe
Investors in Medical Devices (Seed), Investors in AgTech (Series A), Investors in Pharmaceuticals (Seed), Investors in Food and Beverage (Seed), Investors in AgTech (Seed), Investors in Consumer Health (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Food and Beverage (Series A), Investors in ClimateTech/CleanTech (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in AI (Seed), Investors in Manufacturing (Series A), Investors in BioTech (Series A), Investors in Manufacturing (Seed), Investors in AgTech (Seed), Investors in Israel (Other Lists), Investors in AgTech (Seed), Investors in AgTech (Seed), Investors in AI (Seed), Investors in AI (Seed), Investors in Pharmaceuticals (Series A), Investors in AI (Series A), Investors in AI (Seed), Investors in AgTech (Seed), Investors in AI (Seed), Investors in AgTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in ClimateTech/CleanTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Consumer Health (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Consumer Health (Seed), Investors in Consumer Health (Seed), Investors in Consumer Health (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Food and Beverage (Seed), Investors in Food and Beverage (Seed), Investors in Food and Beverage (Seed), Investors in Food and Beverage (Seed), Investors in New York City (Other Lists), Investors in Food and Beverage (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in AgTech (Series A), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in AgTech (Series A), Investors in Manufacturing (Seed), Investors in Manufacturing (Seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Seed), Investors in Manufacturing (Seed), Investors in AI (Series A), Investors in BioTech (Series A), Investors in Manufacturing (Seed), Investors in Pharmaceuticals (Seed), Investors in AgTech (Series A), Investors in AI (Series A), Investors in AI (Series A), Investors in AgTech (Series A), Investors in AgTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Manufacturing (Seed), Investors in ClimateTech/CleanTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Consumer Health (Series A), Investors in Consumer Health (Series A), Investors in Consumer Health (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in Food and Beverage (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Food and Beverage (Series A), Investors in Food and Beverage (Series A), Investors in Consumer Health (Series A), Investors in Food and Beverage (Series A), Investors in Food and Beverage (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Series A), Investors in Manufacturing (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Manufacturing (Series A), Investors in Health & Hospital Services (Series A), Investors in Manufacturing (Series A), Investors in Pharmaceuticals (Series A), Investors in Manufacturing (Series A), Investors in Health & Hospital Services (Series A), Investors in Manufacturing (Series A), Investors in Boston / New England (Other Lists), Investors in AgTech (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in AgTech (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in AgTech (Pre-seed), Investors in AgTech (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in AgTech (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in AI (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in AgTech (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in BioTech (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in BioTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in AI (Seed), Investors in Health & Hospital Services (Seed)
Photo of Cris De Luca, Partner at Sanofi Ventures
Cris De Luca
Sweet spot: $7.5M
Range: $5.0M - $10.0M
Investors in Paris (France), Investors in Israel, Investors in New York (NY), Investors in Europe, Investors in San Francisco (CA), Investors in Cambridge (MA)
Investors in AR/VR (Series A), Investors in AR/VR (Series B), Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in Consumer Health (Series A), Investors in Medical Devices (Series B), Investors in IoT (Series B), Investors in Medical Devices (Series A), Investors in IoT (Series A), Investors in Pharmaceuticals (Series B), Investors in Diverse Investors (Other Lists), Investors in Pharmaceuticals (Series A), Investors in Investors who were founders (Other Lists), Investors in Health IT (Series A), Investors in Investors who invested in female founders (Other Lists), Investors in Israel (Other Lists), Investors in AI (Series A), Investors in Investors who invested in diverse founders (Other Lists), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists), Investors in AR/VR (Series A), Investors in AR/VR (Series A), Investors in AI (Series A), Investors in AI (Series A), Investors in AR/VR (Series A), Investors in AI (Series A), Investors in AR/VR (Series A), Investors in Consumer Health (Series A), Investors in Consumer Health (Series A), Investors in Consumer Health (Series A), Investors in AI (Series A), Investors in Consumer Health (Series A), Investors in IoT (Series A), Investors in IoT (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in IoT (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in IoT (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in AR/VR (Series B), Investors in Pharmaceuticals (Series A), Investors in AI (Series B), Investors in AR/VR (Series B), Investors in Pharmaceuticals (Series A), Investors in AI (Series B), Investors in Consumer Health (Series B), Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in Consumer Health (Series B), Investors in AR/VR (Series B), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in AI (Series B), Investors in AR/VR (Series B), Investors in IoT (Series B), Investors in Health IT (Series B), Investors in Health IT (Series B), Investors in IoT (Series B), Investors in IoT (Series B), Investors in IoT (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Boston / New England (Other Lists), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Digital Health (Series B), Investors in Diagnostics (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series A)
Photo of Gur Roshwalb, Partner at aMoon Fund
Gur Roshwalb
aMoon Fund·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Israel
Photo of Reut Shema, Managing Director at aMoon Fund
Reut Shema
aMoon Fund·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Israel
Photo of Jeff Finkle, Managing Partner at Arcview Ventures
Jeff Finkle
Arcview Ventures·Managing Partner
Sweet spot: $150K
Range: $50K - $250K
Investors in United States, Investors in New York (NY), Investors in Israel, Investors in Canada
Investors in Retail (Seed), Investors in AgTech (Series A), Investors in Pharmaceuticals (Seed), Investors in AgTech (Seed), Investors in Media/Content (Seed), Investors in BioTech (Seed), Investors in Retail (Series A), Investors in Media/Content (Series A), Investors in AgTech (Seed), Investors in AgTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in AgTech (Seed), Investors in BioTech (Seed), Investors in Israel (Other Lists), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Consumer Internet (Seed), Investors in Consumer Internet (Seed), Investors in Consumer Internet (Seed), Investors in New York City (Other Lists), Investors in Media/Content (Seed), Investors in Media/Content (Seed), Investors in Consumer Internet (Seed), Investors in Retail (Seed), Investors in SaaS (Seed), Investors in Retail (Seed), Investors in Media/Content (Seed), Investors in SaaS (Seed), Investors in Retail (Seed), Investors in Pharmaceuticals (Seed), Investors in SaaS (Seed), Investors in Pharmaceuticals (Seed), Investors in AgTech (Series A), Investors in Pharmaceuticals (Seed), Investors in AgTech (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in AgTech (Series A), Investors in Consumer Internet (Series A), Investors in Consumer Internet (Series A), Investors in BioTech (Series A), Investors in Consumer Internet (Series A), Investors in Retail (Series A), Investors in Media/Content (Series A), Investors in Media/Content (Series A), Investors in Retail (Series A), Investors in Media/Content (Series A), Investors in SaaS (Series A), Investors in SaaS (Series A), Investors in Retail (Series A), Investors in SaaS (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Canada (Other Lists), Investors in SaaS (Series A), Investors in Consumer Internet (Series A), Investors in SaaS (Seed)
Photo of Ittai Harel, Managing Partner at Pitango Venture Capital
Ittai Harel
Pitango Venture Capital·Managing Partner
Sweet spot: $5.0M
Range: $1M - $10.0M
Investors in Israel
Investors in AgTech (Series B), Investors in Medical Devices (Seed), Investors in Consumer Health (Series B), Investors in AgTech (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in AgTech (Seed), Investors in Consumer Health (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Seed), Investors in AgTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in Israel (Other Lists), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in AgTech (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in AgTech (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Tomer Berkovitz, General Partner at aMoon Fund
Tomer Berkovitz
aMoon Fund·General Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Israel
Photo of Isaac Devash, General Partner at aMoon Fund
Isaac Devash
aMoon Fund·General Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Israel